Summary
The FDA is halting production of compounded tirzepatide, a cheaper alternative to Eli Lilly’s obesity drug Zepbound, as it declares the shortage over.
Patients who relied on compounded versions, like fear losing access due to high brand-name costs. Some are stockpiling, while others consider risky gray-market sources.
Compounding pharmacies will stop production but can sell remaining stock.
Critics argue that Eli Lilly’s discount programs are insufficient, leaving many unable to afford the branded medication.
Lot of faces getting eaten again.
This is gonna sound a bit ableist, but for the vast majority of obese people, going outside and exercising is a cheap option thats always been available
Eh. You’re not wrong going outside is an option, but it’s not like a 400lbs person can reasonably exercise with out huge risk of injury. Hell there are 300lbs people who can’t due to strain in their frames. Past that exercises isn’t the be all end all of losing weight. You simply can’t outrun your fork and most of these medicines assist with lowering appetite and making eating less fulfilling. Past that there are many mental issues overweight folks can be suffering from involving food dependency.
So for a vast majority of obese people going outside isn’t going to do shit. If they get back in and feel like crap and eat away their sorrow they are just wasting their time. These medicines remove a lot of those non tangible roadblocks. Ultimately yeah we’d all be better getting a jog in when we can but you have to understand at some point the human body just can’t move on its own like that any more.
